Clinical study of INtubate-SURfactant-Extubate to CPAP method in the prevention and treatment for neonatal  respiratory distress syndrome.

doi:10.11852/zgetbjzz2015-23-01-28

Abstract

Abstract: Objective To investigate the effectiveness of INtubate-SURfactant-Extubate to CPAP (INSURE) method in premature infants with respiratory distress syndrome(NRDS). Methods A total of 127 prematures with NRDS from January 2011 to December 2012 were recruited,and data were collected retrospectively.Early outcomes(the PS repeatment,pneumorrhagia,air leak syndrome,PPHN,PDA),late outcome(BPD,ROP,IVH,PVL),complications related with infection(septicemia,NEC) as well as prognosis were compared between two groups. Results There was no statistically difference in general conditions between two groups (P>0.05).The second PS need,pneumorrhagia and air leak syndrome as well as PPHN were significantly decreased in INSURE group (P<0.05).INSURE group had less cases with infectious diseases as septicemia (P<0.05).There was no statistically difference (P>0.05) in the late outcomes such as BPD,ROP,IVH and PVL between two groups.The prognosis such as cure rate and mortality showed no difference in two groups (P>0.05). Conclusions Compared with MV,INSURE can improve the early outcome of NRDS by alleviating NRDS severity,reducing the second PS need,decreasing pneumorrhagia,air leak symdrome and PPHN.It also lowers septicemia.It shorts the total oxygen therapy time,without increasing the occurance of BPD,ROP,IVH,PVL and the mortality.

Key words: INSURE method, neonatal respiratory distress syndrome, clinical study

摘要： 目的通过与传统气管插管机械通气(mechanical ventilation,MV)比较,分析气管插管-肺表面活性物质-拔管使用持续气道正压通气(INtubate-SURfactant-Extubate to CPAP,INSURE)技术防治新生儿呼吸窘迫综合征(neonatal respiratory distress syndrome,NRDS)的作用。方法回顾性分析2011年1月-2012年12月采用INSURE技术(INSURE组)或机械通气(MV组)治疗的127例NRDS患儿,比较两组患儿早期结局(二次使用PS、肺出血、气漏综合症、PPHN、PDA)、晚期结局(BPD、ROP、IVH、PVL);与感染相关并发症(败血症、NEC);预后。结果 1)两组患儿一般情况具有可比性(P>0.05);2)早期结局:INSURE组二次使用PS、肺出血、气漏综合症、PPHN均低于MV组(P<0.05);3)感染相关并发症:败血症发生率更低(P值均<0.05);4)晚期结局:INSURE组BPD、ROP、IVH(III级以上)及PVL与MV组比较差异无统计学意义(P>0.05);5)预后:两组死亡率及治愈率差异无统计学意义(P>0.05)。结论 INSURE技术能更好改善NRDS患儿早期结局,减少二次PS使用,降低肺出血、气漏综合症、PPHN发生;降低败血症的发生;缩短用氧时间;未增加BPD、ROP、IVH、PVL的发生率及死亡率。

关键词: INSURE技术, 新生儿呼吸窘迫综合症, 临床研究

CLC Number:

R725.6

LI Hua,WEI Hong. Clinical study of INtubate-SURfactant-Extubate to CPAP method in the prevention and treatment for neonatal respiratory distress syndrome.[J]. journal1, 2015, 23(1): 87-89.

李花,韦红. INSURE技术防治新生儿呼吸窘迫综合征的临床研究[J]. 中国儿童保健杂志, 2015, 23(1): 87-89.

References

[1] 侯德红,朱荣平.新生儿机械通气常见并发症临床特点分析[J].实用临床医药杂志,2008,12(7):95-96.
[2] Sweet D,Bevilacqua G,Carnielli V,et al.European consensus guidelines on the management of neonatal respiratory distress syndrome[J].Perinat Med,2007,35(1):175-186.
[3] Sweet D,Carnielli V,Greisen G,et al.European consensus guidelines on the management of neonatal respiratory distress syndrome in preterm infants-2010 update[J].Neonatology,2010,97(4):402-417.
[4] Dani C,Corsini I,Bertini G.Effect of multiple INSURE procedures in extremely preterm infants[J].Journal of Maternal-Fetal and Neonatal Medicine,2011,24(12):1427-1431.
[5] Verder H.Nasal CPAP has become an indispensable part of the primary treatment of newborns with respiratory distress syndrome[J].Acta Paediatr,2007,96(4):482-484.
[6] Buettiker V,HugM I,Baenziger O.Advantages and disadvantages of different nasal CPAP systems in newborns[J].Intensive CareMed,2004,30(5):926-930.
[7] Stevens TP,Blennow M,Myers EH,et al.Early surfactant administration with brief ventilation vs selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome[J].Cohrane Database Syst Rev,2007,4:CD003063.
[8] 黄西林,陈丹,李小萍.INSURE策略治疗新生儿呼吸窘迫综合征的临床研究[J].中国当代儿科杂志,2013,15(1):9-13.
[9] Rojas MA,Lozano JM,Rojas MX,et al.Very early surfactant without mandatory ventilation in premature infants treated with early continuous positive airway pressure:a randomized,controlled trial[J].Pediatrics,2009,123(1):137-142.
[10] Dani C,Corsini I,Bertini G,et al.The INSURE method in preterm infants of less than 30 weeks' gestation[J].Maternal-Fetal Neonatal Med,2010,23(9):1024-1029.
[11] Saianda A,Fernandes RM,Saldanha J.Early nasal continuous positive airway pressure versus INSURE in VLBW neonates[J].Rev Port Pneumol,2010,5:779-795.
[12] Dani C,Bertini G.Early extubation and nasal continuous positive airway pressure after surfactant treatment for respiratory distress syndrome among preterm infants <30 weeks' gestation[J].Pediatrics,2004,113(6):e560 -e563.
[13] Reininger A,Khalak R,Kendig JW,et al.Surfactant administration by transient intubation in infants 29-35 weeks' gestation with respiratory distress syndrome decreases need of later mechanical ventilation:a randomised controlled trial[J].Perinatol,2005,25(11):703-708.
[14] Kirsten GF,Kirsten CL.The outcome of ELBW infants treated with NCPAP and inSurE in a resource-limited institution[J].Pediatrics,2012,129(4):e952-e959.

Clinical study of INtubate-SURfactant-Extubate to CPAP method in the prevention and treatment for neonatal respiratory distress syndrome.

INSURE技术防治新生儿呼吸窘迫综合征的临床研究

PDF

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 13

Recommended Articles

Metrics

[1]	NI Song-pin, HUA Xiao-zhen, ZHANG Su-chun. Impact of type 2 diabetes mellitus and gestational diabetes mellitus on neonatal respiratory distress syndrome [J]. Chinese Journal of Child Health Care, 2022, 30(4): 450-453.
[2]	DONG Meng-yuan, JI Ling, LIU Meng-meng, ZHU Xiao-fan, WANG Hui-juan. Analysis of risk factors for bronchopulmonary dysplasia in preterm infants with respiratory distress syndrome [J]. Chinese Journal of Child Health Care, 2021, 29(6): 685-688.
[3]	ZHANG Ya-min, BI Mei-rong, HE Xue-jia, WANG Ying, ZHANG Nan, ZHU Wei-wei. Analysis on the intestinal flora of infants with neonatal respiratory distress syndrome [J]. Chinese Journal of Child Health Care, 2021, 29(10): 1133-1136.
[4]	GENG Jia-qing, FANG Cheng-zhi, ZHANG Bing-hong. Clinical analysis of vitamin D and respiratory distress syndrome in preterm infants [J]. journal1, 2020, 28(3): 345-348.
[5]	RUAN Min-yi, RAO Hong-ping, YANG Yong, ZHANG Lan, SU Jin-zhen, LI Min-xu. Study on the clinical security of sustained lung inflation in low-birth-weight preterm infants with neonatal respiratory distress syndrome [J]. journal1, 2019, 27(10): 1079-1083.
[6]	YANG Nan, CUI Hong, XU Jun-mei. Risk factors and respiratory disease related follow-up analysis of bronchopulmonary dysplasia in premature infants with respiratory distress syndrome [J]. journal1, 2019, 27(10): 1098-1101.
[7]	QIU Jian-wu , DIAO Shi-guang , LIU Xiao-yan， ZENG Ya-li, HU Li, WANG Dong-mei, CHEN Ya-li, ZHANG Jian. Effects of exogenous pulmonary surfactant on immune function in infant with neonatal respiratory distress syndrome [J]. journal1, 2018, 26(6): 619-621.
[8]	FU Shu-fang,XU Zhi-liang. Detection and significance of plasma D-dimer in early neonatal common diseases [J]. journal1, 2017, 25(2): 180-182.
[9]	LU Hong-ru,ZHANG Xiao-yan,MA Xiao-ning,ZHAO Ling,LIU Hong-hong,ZHANG Qin.. Analysis of realted factors of neonatal respiratory distress syndrome combined bronchopulmonary dysplasia. [J]. journal1, 2016, 24(11): 1203-1205.
[10]	ZHONG Xin-qi,CUI Qi-liang,HUANG Wei-min,LIN Li-li. Preventive effect of pulmonary surfactant on neonatal respiratory distress syndrome in preterm infants [J]. journal1, 2015, 23(4): 422-424.
[11]	MENG Jun,WU Hong-tao. Study on vitamin A and mineral substance in neonatal respiratory distress syndrome [J]. journal1, 2015, 23(11): 1221-1223.
[12]	QU Wen-wen,FAN Han-xiao,XIE Lu,HAN Xiao,YIN Xiao-juan. Analysis the risk factors of 893 cases of neonatal respiratory distress syndrome [J]. journal1, 2013, 21(10): 1071-1074.
[13]	LIU Xi-hong, SUN Bo, LIU Hai-hong, YAN Xian-zhong, DING Zong-yi, FENG Zhi-chun. Metabonomic research based on ¹H-NMR in preterm infants with neonatal respiratory distress syndrome(NRDS) [J]. journal1, 2011, 19(2): 104-107.